I read what you are saying, but you are telling me not to

New Post Public Reply Private Reply Replies (1) Message Board
hylander Zolis_onkel #16898
317
I read what you are saying, but you are telling me not to comment with the same statements, but all I am seeing are the same statements days, weeks, months literally.

Joe is doing this, or Joe is doing that or not to worry because this is going to happen.

The problem is, we really don't know. We hear this or we hear that, then everything changes. Then we do not hear a word.

Then we 'assume' this is going to happen. You do know what the word assume usually means to you and me?

NGIO has been moved again and again and everyone is making excuses with no validity, only wishes about funding that may or may not materialize. I hope it does materialize, I really do.

But, right now, we only know the history of what was stated, what has been done and what has not been done. I go by facts and by history.

What I am currently seeing overall is CCs and PRs that have stated plainly one thing and showing something different with no follow-up to explain exactly why.

Again, we can assume all we want, but it doesn't change what's going on and the fact we could very well be here in 6 more months continuing to assume the very same things.

We were told the Form 10 was needed then the S1. It's as simple as that. Nothing else. We can assume anything. Joe wants the funding to push everything through the roof, Joe wants NGIO to look spectacular, who knows. But nothing was said, other than the SEC needed the Form 10 put in and approved first, then the S1, which the S1 was going in right after the Dividend mind you.

I think it was you who put out the 120 days for BARDA now. So, in fact, Generex might not know for a good bit if they get the funding or not. If they are waiting months more to file the S1 until they hear from BARDA, then is NGIO not as stable as anyone thinks or is Generex not capable of doing more than one thing at once?

I hope that all of this works out for the sake of everyone involved. The Generex / NGIO teams and the shareholders. I just hope that Generex management does not drag their feet to long and everyone suffers because of it.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NPKI Faces Legal Scrutiny After Financial Setback

Updated Category News Views 63

Stockholders Left Scrambling You ever have one of those days where everything is cruising along, then bam—you hit what feels like a pothole the size of Texas? Well, that's NPK International (NYSE: NPKI) right now. Their recent revenue cut sent shareholders spiraling, and now there's a legal storm brewing, led by Levi & Korsinsky. Weather Woes Lead to Lower Earnings So,...

Continue Reading
BCD Travel Faces Class Action Probe After Data Breach

Updated Category News Views 81

Class Action Stirred by BCD Travel Data Breach Here's the scoop, folks: Edelson Lechtzin LLP, a heavyweight in the world of class action law firms, is sniffing around BCD Travel Services B.V. over a juicy data breach that left about 700,000 traveler records flapping in the wind. Grab your coffee—this one's got all the trimmings of a modern-day digital fiasco. The Breach...

Continue Reading
Aurora Innovation Faces Supply Chain Hurdles & Legal Scrutiny

Updated Category News Views 88

Aurora's Rough Road: Production Delays Unveiled You could almost hear the collective groan from investors when Aurora Innovation dropped the bombshell about its truck production delays. You know, after the cheery faces at the Q3 financial results reveal gave way to a rather grim reality check—driverless trucking ain't rolling out quite as planned thanks to those pesky...

Continue Reading
Legacy of Professor Raymond Yukna: A Laser Pioneer

Updated Category News Views 66

End of an Era in Periodontology For those of us who have a stake in the world of dental technology, today hangs heavy. We talk about innovators, pioneers, and game-changers all the time, but Dr. Raymond A. Yukna wasn't just another name on that list - he was the list. The guy practically wrote the book on modern periodontal therapy. With his passing, we're not just saying...

Continue Reading
Chemours Class Action: Key Deadline Approaches Fast

Updated Category News Views 56

A Rocky Ride for Chemours Investors The ticker might read NYSE:CC, but right now, that might as well stand for "Caution, Cautious," if you ask me. Investors are on high alert with Chemours facing a class action lawsuit, and the stakes couldn’t be higher. Deadline's looming on December 7, 2026, for those gunning for lead plaintiff status. It's a tense time for anyone who...

Continue Reading
Principle Health Expands Missouri, Illinois Imaging Services

Updated Category News Views 84

Diving Deeper into Principle's Strategic Move Principle Health Systems just took a sizable step by acquiring assets from a mobile diagnostic imaging company around St. Louis. Now they're elbow-deep into Missouri and Illinois, beefing up their ability to deliver bedside X-rays, ultrasounds, and EKGs straight to the patients in long-term care facilities. It ain't just about...

Continue Reading
Investigation of Maplebear Sale to DoorDash Sparks Debate

Updated Category News Views 174

Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...

Continue Reading
Ensign Lawsuit Deadline Looms: Investors, Wake Up!

Updated Category News Views 77

A Storm Brewing in Healthcare Here's what will make any half-savvy investor's pulse quicken: The Ensign Group, Inc. (NasdaqGS: ENSG) is in hot legal water, and there's a hefty class action floating around with some serious allegations. ClaimsFiler's got the word out, marking December 7, 2026, as the cut-off date for investors wanting to be part of this securities class...

Continue Reading
SAMILBIO Gambles on 'Chaeyun' Launch With November Events

Updated Category News Views 25

Can SAMILBIO's New Products Make a Splash? In a world where skincare is more competitive than a hot dog stand outside a vegan festival, here comes SAMILBIO with their latest offerings. Launching a whitening cream and an acne-fighting gel under the 'Chaeyun' brand, this company isn't just sticking to digital—it's diving into face-to-face consumer interaction. I mean,...

Continue Reading
Springbrook's AI Push: Transforming Local Governance

Updated Category News Views 116

Revolutionizing Government Tech with AI Springbrook Software is positioning itself as a frontrunner in modernizing government tech, unveiling a suite of AI-driven innovations under its Cirrus ERP platform. During their recent conference, Activate 2026, held in Orlando, the commitment to transforming how local governments operate was clear. With new tools like AI Invoicing...

Continue Reading

Top 5 Most Recently Viewed Articles

Pita Pit USA Strengthens Its Roots with New Location Launch

Updated Category News Views 161

Pita Pit USA Strengthens Its Roots with New Location Launch Former tech executive, Bruce Foreman, a native of Montana, is set to introduce a new dining experience focused on community through Pita Pit USA. This Mediterranean fast-casual chain is known for its made-to-order pita sandwiches and aims to provide a fresh and healthy alternative for diners. Bruce, who hails...

Continue Reading
Stratos Solutions Chooses Unanet for ERP to Foster Growth

Updated Category News Views 50

Stratos Solutions Chooses Unanet for ERP to Foster Growth In a significant move to support its expansion, Stratos Solutions Inc. (SSI) has decided to adopt Unanet ERP GovCon, stepping away from the challenges of using an off-the-shelf financial system. This change reflects the company's commitment to enhancing efficiency while remaining true to its core values and...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 22

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Esquire Financial Holdings Declares New Quarterly Dividend

Updated Category News Views 147

Esquire Financial Holdings, Inc. Announces Quarterly Dividend Esquire Financial Holdings, Inc. (NASDAQ: ESQ), a key player in the financial services sector, has recently announced its regular quarterly dividend of $0.175 per share, which is set to benefit its common stockholders. This decision underscores the company's commitment to rewarding shareholders while remaining...

Continue Reading
Gladstone Commercial Reaches Milestone with 52-Week High

Updated Category News Views 117

Gladstone Commercial Achieves New Stock Milestone Gladstone Commercial (NASDAQ: GOOD) has recently reached a significant milestone in its stock performance, hitting a 52-week high at $17.54 in a thriving market. This achievement is a reflection of the real estate investment trust's stability, which primarily focuses on long-term net leased industrial and office...

Continue Reading